Cargando…
Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis
BACKGROUND AND AIMS: Alcoholic liver disease (ALD) is characterized by impaired liver function due to chronic alcohol consumption, even fatal in severe cases. We performed a meta-analysis to determine whether microbial agents have therapeutic potential for ALD and elucidate the underlying mechanisms...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719948/ https://www.ncbi.nlm.nih.gov/pubmed/36479298 http://dx.doi.org/10.3389/fnut.2022.1054265 |
_version_ | 1784843440809312256 |
---|---|
author | Wang, Qinjian Shi, Jiangmin Zhao, Min Ruan, Gaoyi Dai, Zebin Xue, Yilang Shi, Dibang Xu, Changlong Yu, Ouyue Wang, Fangyan Xue, Zhanxiong |
author_facet | Wang, Qinjian Shi, Jiangmin Zhao, Min Ruan, Gaoyi Dai, Zebin Xue, Yilang Shi, Dibang Xu, Changlong Yu, Ouyue Wang, Fangyan Xue, Zhanxiong |
author_sort | Wang, Qinjian |
collection | PubMed |
description | BACKGROUND AND AIMS: Alcoholic liver disease (ALD) is characterized by impaired liver function due to chronic alcohol consumption, even fatal in severe cases. We performed a meta-analysis to determine whether microbial agents have therapeutic potential for ALD and elucidate the underlying mechanisms. METHODS AND RESULTS: Forty-one studies were eligible for this meta-analysis after searching the PubMed, Cochrane, and Embase databases. The combined analysis showed that microbial therapy significantly decreased hepatic enzymatic parameters, including alanine transaminase [standardized mean difference (SMD): –2.70, 95% confidence interval (CI): –3.33 to –2.07], aspartate aminotransferase (SMD: –3.37, 95% CI: –4.25 to –2.49), γ-glutamyl transpeptidase (SMD: -2.07, 95% CI: –3.01 to –1.12), and alkaline phosphatase (SMD: –2.12, 95% CI: –3.32 to –0.92). Microbial agents endotoxin to enter the portal circulation and increasing reduced total cholesterol (SMD = -2.75, 95%CI -4.03 to -1.46) and triglycerides (SMD = –2.64, 95% CI: –3.22 to –2.06). Microbial agents increased amounts of the beneficial flora Lactobacillus (SMD: 4.40, 95% CI: 0.97–7.84) and Bifidobacteria (SMD: 3.84, 95% CI: 0.22–7.45), Bacteroidetes (SMD: 2.51, 95% CI: 0.29–4.72) and decreased harmful Proteobacteria (SMD: –4.18, 95% CI: –6.60 to –1.77), protecting the integrity of the intestinal epithelium and relieving endotoxin (SMD: –2.70, 95% CI: -3.52 to –2.17) into the portal vein, thereby reducing the production of inflammatory factors such as tumor necrosis factor-α (SMD: –3.35, 95% CI: –4.31 to –2.38), interleukin-6 (SMD: –4.28, 95% CI: –6.13 to –2.43), and interleukin-1β (SMD: –4.28, 95% CI: –6.37 to –2.19). Oxidative stress was also relieved, as evidenced by decreased malondialdehyde levels (SMD: –4.70, 95% CI: –6.21 to –3.20). Superoxide dismutase (SMD: 2.65, 95% CI: 2.16–3.15) and glutathione levels (SMD: 3.80, 95% CI: 0.95–6.66) were elevated. CONCLUSION: Microbial agents can reverse dysbiosis in ALD, thus significantly interfering with lipid metabolism, relieving inflammatory response and inhibiting oxidative stress to improve liver function. |
format | Online Article Text |
id | pubmed-9719948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97199482022-12-06 Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis Wang, Qinjian Shi, Jiangmin Zhao, Min Ruan, Gaoyi Dai, Zebin Xue, Yilang Shi, Dibang Xu, Changlong Yu, Ouyue Wang, Fangyan Xue, Zhanxiong Front Nutr Nutrition BACKGROUND AND AIMS: Alcoholic liver disease (ALD) is characterized by impaired liver function due to chronic alcohol consumption, even fatal in severe cases. We performed a meta-analysis to determine whether microbial agents have therapeutic potential for ALD and elucidate the underlying mechanisms. METHODS AND RESULTS: Forty-one studies were eligible for this meta-analysis after searching the PubMed, Cochrane, and Embase databases. The combined analysis showed that microbial therapy significantly decreased hepatic enzymatic parameters, including alanine transaminase [standardized mean difference (SMD): –2.70, 95% confidence interval (CI): –3.33 to –2.07], aspartate aminotransferase (SMD: –3.37, 95% CI: –4.25 to –2.49), γ-glutamyl transpeptidase (SMD: -2.07, 95% CI: –3.01 to –1.12), and alkaline phosphatase (SMD: –2.12, 95% CI: –3.32 to –0.92). Microbial agents endotoxin to enter the portal circulation and increasing reduced total cholesterol (SMD = -2.75, 95%CI -4.03 to -1.46) and triglycerides (SMD = –2.64, 95% CI: –3.22 to –2.06). Microbial agents increased amounts of the beneficial flora Lactobacillus (SMD: 4.40, 95% CI: 0.97–7.84) and Bifidobacteria (SMD: 3.84, 95% CI: 0.22–7.45), Bacteroidetes (SMD: 2.51, 95% CI: 0.29–4.72) and decreased harmful Proteobacteria (SMD: –4.18, 95% CI: –6.60 to –1.77), protecting the integrity of the intestinal epithelium and relieving endotoxin (SMD: –2.70, 95% CI: -3.52 to –2.17) into the portal vein, thereby reducing the production of inflammatory factors such as tumor necrosis factor-α (SMD: –3.35, 95% CI: –4.31 to –2.38), interleukin-6 (SMD: –4.28, 95% CI: –6.13 to –2.43), and interleukin-1β (SMD: –4.28, 95% CI: –6.37 to –2.19). Oxidative stress was also relieved, as evidenced by decreased malondialdehyde levels (SMD: –4.70, 95% CI: –6.21 to –3.20). Superoxide dismutase (SMD: 2.65, 95% CI: 2.16–3.15) and glutathione levels (SMD: 3.80, 95% CI: 0.95–6.66) were elevated. CONCLUSION: Microbial agents can reverse dysbiosis in ALD, thus significantly interfering with lipid metabolism, relieving inflammatory response and inhibiting oxidative stress to improve liver function. Frontiers Media S.A. 2022-11-21 /pmc/articles/PMC9719948/ /pubmed/36479298 http://dx.doi.org/10.3389/fnut.2022.1054265 Text en Copyright © 2022 Wang, Shi, Zhao, Ruan, Dai, Xue, Shi, Xu, Yu, Wang and Xue. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Wang, Qinjian Shi, Jiangmin Zhao, Min Ruan, Gaoyi Dai, Zebin Xue, Yilang Shi, Dibang Xu, Changlong Yu, Ouyue Wang, Fangyan Xue, Zhanxiong Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis |
title | Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis |
title_full | Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis |
title_fullStr | Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis |
title_full_unstemmed | Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis |
title_short | Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis |
title_sort | microbial treatment of alcoholic liver disease: a systematic review and meta-analysis |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719948/ https://www.ncbi.nlm.nih.gov/pubmed/36479298 http://dx.doi.org/10.3389/fnut.2022.1054265 |
work_keys_str_mv | AT wangqinjian microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT shijiangmin microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT zhaomin microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT ruangaoyi microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT daizebin microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT xueyilang microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT shidibang microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT xuchanglong microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT yuouyue microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT wangfangyan microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis AT xuezhanxiong microbialtreatmentofalcoholicliverdiseaseasystematicreviewandmetaanalysis |